Topamax Birth Defects Studies
In July 2012, the American Journal of Obstetrics & Gynecology published a study confirming that expecting mothers who used Topamax during their first trimester of pregnancy were five times more likely than women not taking the drug to have a child with a cleft lip or cleft palate. The published study included data from 18,000 female test subjects collected by the Sione Epidemiology Center Birth Defects Prevention Study and National Birth Defects Prevention Study.
The FDA issued a warning in 2011 about the link between Topamax and oral cleft defects such as cleft lips and cleft palates. The agency has upgraded Topamax to its Pregnancy Category D, meaning that the drug has a proven risk of causing birth defects.
If you or a loved one used Topamax while pregnant and gave birth to a child with cleft lip, cleft palate or other birth defects, you may be entitled to file a lawsuit. For a free legal consultation about your case, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.